• Login
    ARAN - Access to Research at NUI Galway
    View Item 
    •   ARAN Home
    • Support Services
    • Externally hosted open access publications with NUI Galway authors (2)
    • View Item
    •   ARAN Home
    • Support Services
    • Externally hosted open access publications with NUI Galway authors (2)
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ARANCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsTypesThis CollectionBy Issue DateAuthorsTitlesSubjectsTypes

    My Account

    LoginRegister

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Help

    How to submit and FAQs

    Applying current screening tools for gestational diabetes mellitus to a european population: is it time for change?

    Thumbnail
    View/Open
    Full Text
    Date
    2013-06-11
    Author
    Avalos, G. E.
    Owens, L. A.
    Dunne, F.
    ,
    Metadata
    Show full item record
    Usage
    This item's downloads: 0 (view details)
    Cited 54 times in Scopus (view citations)
    
    Recommended Citation
    Avalos, G. E. Owens, L. A.; Dunne, F.; , (2013). Applying current screening tools for gestational diabetes mellitus to a european population: is it time for change?. Diabetes Care 36 (10), 3040-3044
    Published Version
    http://care.diabetesjournals.org/content/diacare/36/10/3040.full.pdf
    Abstract
    OBJECTIVEThe optimal screening regimen for gestational diabetes mellitus (GDM) remains controversial. Risk factors used in selective screening guidelines vary. Given that universal screening is not currently adopted in our European population, we aimed to evaluate which selective screening strategies were most applicable.RESEARCH DESIGN AND METHODSBetween 2007 and 2009, 5,500 women were universally screened for GDM, and a GDM prevalence of 12.4% using International Association of Diabetes in Pregnancy Study Groups (IADPSG) criteria was established. We retrospectively applied selective screening guidelines to this cohort.RESULTSWhen we applied National Institute for Health and Clinical Excellence (NICE), Irish, and American Diabetes Association (ADA) guidelines, 54% (2,576), 58% (2,801), and 76% (3,656) of women, respectively, had at least one risk factor for GDM and would have undergone testing. However, when NICE, Irish, and ADA guidelines were applied, 20% (120), 16% (101), and 5% (31) of women, respectively, had no risk factor and would have gone undiagnosed. Using a BMI 30 kg/m(2) for screening has a specificity of 81% with moderate sensitivity at 48%. Reducing the BMI to 25 kg/m(2) (ADA) increases the sensitivity to 80% with a specificity of 44%. Women with no risk factors diagnosed with GDM on universal screening had more adverse pregnancy outcomes than those with normal glucose tolerance.CONCLUSIONSThis analysis provides a strong argument for universal screening. However, if selective screening were adopted, the ADA guidelines would result in the highest rate of diagnosis and the lowest number of missed cases.
    URI
    http://hdl.handle.net/10379/10309
    Collections
    • Externally hosted open access publications with NUI Galway authors (2)
    • Copyright @ NUI Galway
    • Library
    • NUI Galway